Home > Boards > US Listed > Biotechs > Sage Therapeutics, Inc. (SAGE)

If Sage has such a great new depression

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
whatsUP8 Member Profile
 
Followed By 0
Posts 2
Boards Moderated 0
Alias Born 12/20/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 9:03:44 AM
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection Business Wire - 6/14/2019 8:53:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2019 4:37:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:04 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 6/5/2019 6:30:00 AM
Sage Therapeutics to Present at Goldman Sachs 40th Annual Global Healthcare Conference Business Wire - 6/4/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:04:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 6:26:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 4:02:12 PM
Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Health... PR Newswire (US) - 5/23/2019 9:06:00 AM
Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference Business Wire - 5/14/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/10/2019 4:36:46 PM
Sage Therapeutics to Present at Bank of America Merrill Lynch 2019 Health Care Conference Business Wire - 5/7/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/6/2019 6:22:29 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 5/6/2019 4:45:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 7:26:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 7:17:27 AM
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress Business Wire - 5/2/2019 6:30:00 AM
whatsUP8   Wednesday, 12/20/17 12:23:57 PM
Re: None
Post # of 81 
If Sage has such a great new depression drug tested on only 86 patients, why is their Chief Scientific Officer selling all his shares now? His recent sales are posted in the News Section on SEC Form 4.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist